These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9186684)

  • 61. B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses.
    Rossetti RAM; Lorenzi NPC; Yokochi K; Rosa MBSF; Benevides L; Margarido PFR; Baracat EC; Carvalho JP; Villa LL; Lepique AP
    PLoS One; 2018; 13(7):e0199034. PubMed ID: 29975708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
    Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.
    Lederman S; Yellin MJ; Cleary AM; Pernis A; Inghirami G; Cohn LE; Covey LR; Lee JJ; Rothman P; Chess L
    J Immunol; 1994 Mar; 152(5):2163-71. PubMed ID: 7907632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes.
    Ribbens C; Dayer JM; Chizzolini C
    Immunology; 2000 Feb; 99(2):279-86. PubMed ID: 10692048
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IL-12 in autoimmunity.
    Caspi RR
    Clin Immunol Immunopathol; 1998 Jul; 88(1):4-13. PubMed ID: 9683544
    [No Abstract]   [Full Text] [Related]  

  • 66. In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.
    Chougnet C; Freitag C; Schito M; Thomas EK; Sher A; Shearer GM
    J Immunol; 2001 Mar; 166(5):3210-7. PubMed ID: 11207274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of antigen-presenting cells in mediating tolerance and autoimmunity.
    Garza KM; Chan SM; Suri R; Nguyen LT; Odermatt B; Schoenberger SP; Ohashi PS
    J Exp Med; 2000 Jun; 191(11):2021-7. PubMed ID: 10839816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD40 mediated activation of gingival and periodontal ligament fibroblasts.
    Sempowski GD; Chess PR; Moretti AJ; Padilla J; Phipps RP; Blieden TM
    J Periodontol; 1997 Mar; 68(3):284-92. PubMed ID: 9100204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
    Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
    J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.
    Murphy WJ
    J Clin Invest; 2000 Sep; 106(6):745-7. PubMed ID: 10995784
    [No Abstract]   [Full Text] [Related]  

  • 71. Increased IL-4 production and decreased CD40L expression by newborn T cells contribute to transplantation tolerance.
    Donckier V; Flamand V; Abramowicz D; Goldman M
    Transplant Proc; 1999; 31(1-2):782-3. PubMed ID: 10083333
    [No Abstract]   [Full Text] [Related]  

  • 72. CD40 ligand-transduced co-stimulation of T cells in the development of helper function.
    van Essen D; Kikutani H; Gray D
    Nature; 1995 Dec; 378(6557):620-3. PubMed ID: 8524396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
    Brines RD; Klaus GG
    Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
    Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunology. It takes more than two to tango.
    Schwartz RH
    Nature; 2001 Jan; 409(6816):31-2. PubMed ID: 11343098
    [No Abstract]   [Full Text] [Related]  

  • 76. CD40 ligand/CD40 deficiency.
    Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
    Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
    Cong Y; Weaver CT; Lazenby A; Elson CO
    J Immunol; 2000 Aug; 165(4):2173-82. PubMed ID: 10925304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD40 pathway blockade as an approach to immunotherapy.
    Burkly LC
    Adv Exp Med Biol; 2001; 489():135-52. PubMed ID: 11554588
    [No Abstract]   [Full Text] [Related]  

  • 80. Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.
    Dunnion DJ; Cywinski AL; Tucker VC; Murray AK; Rickinson AB; Coulie P; Browning MJ
    Immunology; 1999 Dec; 98(4):541-50. PubMed ID: 10594686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.